Assessment of competencies of clinical research professionals and proposals to improve clinical research in Portugal
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study assessed clinical research competency in Portugal, revealing knowledge gaps across all eight Joint Task Force for Clinical Trial Competency (JTFCTC) Domains. Recommendations include enhanced training and collaboration to improve study quality and international standards.
Area Of Science
- Clinical Research
- Healthcare Management
- Professional Development
Background
- Multidisciplinary teams coordinate clinical studies but often lack adequate training.
- ROCHE and AICIB (Agency for Clinical Research and Biomedical Innovation) initiated a self-assessment survey in Portugal.
- The survey aimed to evaluate clinical research professional competency and identify priority gaps.
Purpose Of The Study
- To assess the competency of clinical research professionals in Portugal.
- To identify key actions for addressing identified competency gaps.
- To promote the elevation of clinical study quality and compliance with international standards.
Main Methods
- A self-assessment electronic survey was distributed to clinical research professionals across 10 Portuguese centers.
- The survey was adapted and translated from the Joint Task Force for Clinical Trial Competency (JTFCTC) framework.
- Survey results were discussed by representatives from centers, ROCHE, and AICIB to identify gaps and propose recommendations.
Main Results
- 109 participants completed the survey, with a significant proportion being Investigators (44.0%) and having over 10 years of experience (34.9%).
- All eight JTFCTC Domains scored below 60% in knowledge levels, though Investigators generally scored higher.
- Proposed actions include enhancing training, fostering collaboration, and investing in infrastructure.
Conclusions
- This is the first study to assess clinical trial competency in Portugal, with high participation.
- A national collaborative action plan involving various stakeholders is needed.
- Improving competency will enhance study quality, ensure international standard compliance, and benefit researchers and patients.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.